Amniotic membrane transplantation in infectious corneal ulcer

J S Kim1, J C Kim, T W Hahn

  • 1Department of Ophthalmology, Chung-Ang University Hospital, Hangang-Ro 3ka 65-207, Yongsan-ku 140-757, Seoul, Korea.

Cornea
|October 6, 2001
PubMed
Abstract

Insights

Amniotic membrane transplantation effectively managed infectious corneal ulcers by promoting healing and reducing inflammation. This treatment aided corneal surface recovery and improved visual acuity in patients.

Area of Science:

  • Ophthalmology
  • Regenerative Medicine

Background:

  • Infectious corneal ulcers can cause significant corneal damage due to inflammatory responses.
  • Effective management strategies are crucial to prevent vision loss.

Purpose of the Study:

  • To assess the efficacy of amniotic membrane transplantation (AMT) for treated infectious corneal ulcers.
  • To evaluate AMT's role in managing inflammation-induced corneal damage.

Main Methods:

  • A prospective study involved 21 patients with infectious corneal ulcers.
  • Causative organisms were eradicated with antimicrobial agents prior to AMT.
  • Amniotic membranes were soaked in anti-infective agents before transplantation.

Main Results:

  • Successful corneal healing was observed in all cases post-AMT.
  • No recurrence of microbial infection was noted during the follow-up period (mean 18 months).
  • Visual acuity improved in non-scarring cases or after subsequent penetrating keratoplasty.

Conclusions:

  • Amniotic membrane transplantation serves as a valuable adjunctive therapy for infectious corneal ulcers.
  • AMT promotes wound healing and mitigates inflammation, aiding corneal recovery.

Related Concept Videos